CompletedNCT01460290
Asenapine in Older Adults Living With Bipolarity
About this title
Read the official source — NCT01460290Researchers studied Asenapine to find out how it affected depression symptoms in older adults with bipolarity.
Medication studyAges 60+United States
Understand this study
What did researchers investigate?
Researchers studied Asenapine to find out how it affected depression symptoms in older adults with bipolarity.
Who was this study for?
This study was for people with bipolarity. Listed age limits: from 60 years. Other eligibility criteria applied.
- Listed locations
- ClevelandSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateOctober 2011
- Recruitment status
- Completed
- Enrollment listed in the registry
- 15
- Sponsor
- University Hospitals Cleveland Medical Center
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- Over 60 Years
- Official registry ID
- NCT01460290
- Official title
Show the full official title
Asenapine in the Treatment of Older Adults With Bipolar Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Cleveland
Questions about this study
What did researchers investigate?
Researchers studied Asenapine to find out how it affected depression symptoms in older adults with bipolarity.
Who is behind this study?
The study sponsor is University Hospitals Cleveland Medical Center, a university.
Did this study involve medication?
Yes. The study involved medication, including Asenapine.
Who was this study for?
This study was for people with bipolarity. Listed age limits: from 60 years. Other eligibility criteria applied.
